The decision by the US Food and Drug Administration (FDA) on whether millions of Covid-19 vaccines manufactured by Johnson & Johnson (J&J) can be released has been delayed and is likely to come later in the week, the head of SA’s medicines regulator said on Monday.

The FDA is in the process of determining whether substandard manufacturing conditions at troubled J&J contractor Emergent BioSolutions have been fixed. It is also looking into the extent to which the contamination issues it identified earlier this year affect batches of vaccines manufactured by J&J contractors that relied on ingredients supplied by Emergent, including Aspen Pharmacare...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.